drugset / Trial / NCT07300280

A Clinical Trial of Enlicitide and Rosuvastatin in Healthy Adults (MK-0616-039)

NCT07300280

Phase 1 Recruiting 60 enrolled Merck Sharp & Dohme LLC
RandomizedCrossoverOpen-labelBasic science

Summary

This goal of this trial is to learn about two medicines, enlicitide and rosuvastatin, in healthy people. Researchers will compare the amounts of enlicitide and rosuvastatin in a person's body over time, when they are given as separate medicines and when they are combined into one tablet.

Timeline

Start
2025-12-29
Primary completion
2026-10-14
Completion
2026-10-21

Drugs

EvaluationDrugModalityDoseRoute
Subject Enlicitide Unknown Oral
Subject MK-0616A Unknown Oral
Subject Rosuvastatin Small molecule Oral

Indications

No indication recorded.